Carsten Stephan

14.0k total citations · 1 hit paper
248 papers, 10.1k citations indexed

About

Carsten Stephan is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Carsten Stephan has authored 248 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 145 papers in Pulmonary and Respiratory Medicine, 83 papers in Molecular Biology and 54 papers in Cancer Research. Recurrent topics in Carsten Stephan's work include Prostate Cancer Treatment and Research (129 papers), Prostate Cancer Diagnosis and Treatment (105 papers) and Urologic and reproductive health conditions (27 papers). Carsten Stephan is often cited by papers focused on Prostate Cancer Treatment and Research (129 papers), Prostate Cancer Diagnosis and Treatment (105 papers) and Urologic and reproductive health conditions (27 papers). Carsten Stephan collaborates with scholars based in Germany, Canada and United States. Carsten Stephan's co-authors include Klaus Jung, Glen Kristiansen, Michael Lein, Stefan A. Loening, Monika Jung, Kurt Miller, Eleftherios P. Diamandis, Manfred Dietel, George M. Yousef and Dietmar Schnorr and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Carsten Stephan

245 papers receiving 9.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma

2009 524 citations Annika Schaefer, Monika Jung et al. profile →

Peers

Countries citing papers authored by Carsten Stephan

Since Specialization

Citations

This map shows the geographic impact of Carsten Stephan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carsten Stephan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carsten Stephan more than expected).

Fields of papers citing papers by Carsten Stephan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carsten Stephan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carsten Stephan. The network helps show where Carsten Stephan may publish in the future.

Co-authorship network of co-authors of Carsten Stephan

This figure shows the co-authorship network connecting the top 25 collaborators of Carsten Stephan. A scholar is included among the top collaborators of Carsten Stephan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carsten Stephan. Carsten Stephan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical implications of AGR2 in primary prostate cancer: Results from a large‐scale study 2024 ·Apmis ·(unknown), Matteo Montani, (unknown), Carsten Stephan, Klaus Jung, Holger Moch, Daniel Eberli, (unknown), (unknown), (unknown), Marcus V. Cronauer, (unknown), Thomas Mayr, Stefan Hauser, Glen Kristiansen	1
2	Vitamin D Metabolites in Nonmetastatic High-Risk Prostate Cancer Patients with and without Zoledronic Acid Treatment after Prostatectomy 2022 ·Cancers ·Carsten Stephan, Bernhard Ralla, Florian Bonn, (unknown), Michael Lein, Klaus Jung	1
3	Multiparametric Ultrasound (mpUS) of a Rare Testicular Capillary Hemangioma 2019 ·SHILAP Revista de lepidopterología ·(unknown), Thomas Fischer, Carsten Stephan, Andreas Maxeiner, Bernd Hamm, Markus Herbert Lerchbaumer	3
4	Image-guided Irreversible Electroporation of Localized Prostate Cancer: Functional and Oncologic Outcomes 2019 ·Radiology ·Federico Collettini, (unknown), Carsten Stephan, Thomas Fischer, Alexander Baur, Tobias Penzkofer, Jonas Busch, Bernd Hamm, Bernhard Gebauer	54
5	原発性前立腺癌における核AR-V7蛋白質の過剰発現はアジュバント療法を受ける高リスク疾患の男性における独立した陰性予後マーカーである【JST・京大機械翻訳】 2018 ·Urologic Oncology Seminars and Original Investigations ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Carsten Stephan, (unknown), (unknown), (unknown), (unknown), (unknown)	2
6	The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer 2015 ·Clinical Cancer Research ·Heidrun Gevensleben, Dimo Dietrich, Carsten Golletz, Susanne Steiner, Maria Jung, Thore Thiesler, Michael Majores, Johannes Stein, Barbara Uhl, Stefan C. Müller, Jörg Ellinger, Carsten Stephan, Klaus Jung, Peter Brossart, Glen Kristiansen	167
7	Prognostic relevance of proliferation markers (Ki-67, PHH3) within the cross-relation of ERG translocation and androgen receptor expression in prostate cancer 2015 ·Pathology ·Diane Goltz, Matteo Montani, Martin Braun, Sven Perner, Nicolas Wernert, Klaus Jung, Manfred Dietel, Carsten Stephan, Glen Kristiansen	19
8	Risk prediction models for biochemical recurrence after radical prostatectomy using prostate-specific antigen and Gleason score 2014 ·Asian Journal of Andrology ·Jonas Busch, (unknown), Henning Cammann, (unknown), Klaus Jung, (unknown), (unknown), Ahmed Magheli, Carsten Stephan	15
9	Selenoprotein P Status Correlates to Cancer-Specific Mortality in Renal Cancer Patients 2012 ·PLoS ONE ·(unknown), Tobias Endermann, Carsten Stephan, Mette Stoedter, Thomas Behrends, Ingmar Wolff, Klaus Jung, Lutz Schomburg	43
10	The Androgen-Regulated Calcium-Activated Nucleotidase 1 (CANT1) Is Commonly Overexpressed in Prostate Cancer and Is Tumor-Biologically Relevant in Vitro 2011 ·American Journal Of Pathology ·Josefine Gerhardt, (unknown), (unknown), Silvia Behnke, (unknown), Florian Fritzsche, Heike Liewen, Frank Stenner, Peter J. Wild, Thomas Hermanns, Michael Müntener, Manfred Dietel, Klaus Jung, Carsten Stephan, Glen Kristiansen	29
11	Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors 2010 ·Nature Reviews Urology ·Annika Schaefer, Carsten Stephan, Jonas Busch, George M. Yousef, Klaus Jung	98
12	Prevalence of TMPRSS2–ERG and SLC45A3–ERG gene fusions in a large prostatectomy cohort 2010 ·Modern Pathology ·Raquel Esgueva, Sven Perner, Christopher J. Lafargue, Veit Scheble, Carsten Stephan, Michael Lein, Florian Fritzsche, Manfred Dietel, Glen Kristiansen, Mark A. Rubin	121
13	Prostate MR Imaging: Tissue Characterization with Pharmacokinetic Volume and Blood Flow Parameters and Correlation with Histologic Parameters 2009 ·Radiology ·Tobias Franiel, Lutz Lüdemann, Birgit Rudolph, (unknown), Carsten Stephan, Matthias Taupitz, Dirk Beyersdorff	45
14	MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy 2009 ·Journal of Cellular and Molecular Medicine ·Monika Jung, Hans‐Joachim Mollenkopf, Christina Grimm, Ina Wagner, Marco Albrecht, (unknown), Christian Pilarsky, Manfred Johannsen, Carsten Stephan, Hans Lehrach, Wilfried Nietfeld, Thomas Rudel, Klaus Jung, Glen Kristiansen	201
15	Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status 2006 ·British Journal of Cancer ·(unknown), Tserenchunt Gansukh, Carla A. Borgoño, Mick Burkhardt, Stefan Pahl, Émpar Mayordomo, (unknown), Wilko Weichert, Carsten Denkert, Klaus Jung, Carsten Stephan, (unknown), Eleftherios P. Diamandis, Edgar Dahl, Glen Kristiansen	19
16	Motivierende Gesprächsführung mit Arbeitslosen 2006 ·Das Gesundheitswesen ·Reiner Hanewinkel, (unknown), Carsten Stephan, Barbara Isensee, Gudrun Wiborg	8
17	mRNA expression profile of matrix metalloproteinases and their tissue inhibitors in malignant and non-malignant prostatic tissue. 2003 ·PubMed ·Ralf Lichtinghagen, Petra B. Musholt, Carsten Stephan, Michael Lein, Glen Kristiansen, Steffen Hauptmann, Birgit Rudolph, Dietmar Schnorr, Stefan A. Loening, Klaus Jung	15
18	ALCAM/CD166 is up‐regulated in low‐grade prostate cancer and progressively lost in high‐grade lesions 2002 ·The Prostate ·Glen Kristiansen, Christian Pilarsky, Christoph Wissmann, Carsten Stephan, L. Weißbach, V. Loy, Stefan A. Loening, Manfred Dietel, André Rosenthal	118
19	The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia 1997 ·Cancer ·Carsten Stephan, Michael Lein, Klaus Jung, Dietmar Schnorr, Stefan A. Loening	83
20	The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia 1997 ·Cancer ·Carsten Stephan, Michael Lein, Klaus Jung, Dietmar Schnorr, Stefan A. Loening	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact